Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Prostate Cancer

Free Subscription Articles published in Cancer Res Retrieve available abstracts of 234 articles: HTML format

Single Articles

July 2008
1. DEHM SM , Schmidt LJ, Heemers HV, Vessella RL, et al
   Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance.
   Cancer Res. 2008;68:5469-77.
   PubMed     Related articles    Abstract available
   
   
   June 2008
2. YEMELYANOV A , Czwornog J, Gera L, Joshi S, et al
   Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.
   Cancer Res. 2008;68:4763-73.
   PubMed     Related articles    Abstract available
   
   
   
3. LINK KA , Balasubramaniam S, Sharma A, Comstock CE, et al
   Targeting the BAF57 SWI/SNF subunit in prostate cancer: a novel platform to control androgen receptor activity.
   Cancer Res. 2008;68:4551-8.
   PubMed     Related articles    Abstract available
   
   
   
4. MONTGOMERY RB , Mostaghel EA, Vessella R, Hess DL, et al
   Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth.
   Cancer Res. 2008;68:4447-54.
   PubMed     Related articles    Abstract available
   
   
   
5. LIN D , Watahiki A, Bayani J, Zhang F, et al
   ASAP1, a gene at 8q24, is associated with prostate cancer metastasis.
   Cancer Res. 2008;68:4352-9.
   PubMed     Related articles    Abstract available
   
   
   
6. CAMORIANO M , Kinney SR, Moser MT, Foster BA, et al
   Phenotype-specific CpG island methylation events in a murine model of prostate cancer.
   Cancer Res. 2008;68:4173-82.
   PubMed     Related articles    Abstract available
   
   
   May 2008
7. CHEN J , Deng F, Singh SV, Wang QJ, et al
   Protein Kinase D3 (PKD3) Contributes to Prostate Cancer Cell Growth and Survival Through a PKC{varepsilon}/PKD3 Pathway Downstream of Akt and ERK 1/2.
   Cancer Res. 2008;68:3844-53.
   PubMed     Related articles    Abstract available
   
   
   
8. SIVA AC , Wild MA, Kirkland RE, Nolan MJ, et al
   Targeting CUB Domain-Containing Protein 1 with a Monoclonal Antibody Inhibits Metastasis in a Prostate Cancer Model.
   Cancer Res. 2008;68:3759-66.
   PubMed     Related articles    Abstract available
   
   
   
9. JIN RJ , Lho Y, Wang Y, Ao M, et al
   Down-regulation of p57Kip2 Induces Prostate Cancer in the Mouse.
   Cancer Res. 2008;68:3601-8.
   PubMed     Related articles    Abstract available
   
   
   
10. MEHRA R , Tomlins SA, Yu J, Cao X, et al
    Characterization of TMPRSS2-ETS Gene Aberrations in Androgen-Independent Metastatic Prostate Cancer.
    Cancer Res. 2008;68:3584-90.
    PubMed     Related articles    Abstract available
    
    
    
11. ERREN TC , Pape HG, Piekarski C, Reiter RJ, et al
    Not all shifts are equal: it's time for comprehensive exposure metrics in chronodisruption research.
    Cancer Res. 2008;68:4011.
    PubMed     Related articles   
    
    
    
12. SARGEANT AM , Rengel RC, Kulp SK, Klein RD, et al
    OSU-HDAC42, a histone deacetylase inhibitor, blocks prostate tumor progression in the transgenic adenocarcinoma of the mouse prostate model.
    Cancer Res. 2008;68:3999-4009.
    PubMed     Related articles    Abstract available
    
    
    
13. LU X , Yang C, Hill R, Yin C, et al
    Inactivation of gadd45a sensitizes epithelial cancer cells to ionizing radiation in vivo resulting in prolonged survival.
    Cancer Res. 2008;68:3579-83.
    PubMed     Related articles    Abstract available
    
    
    
14. MIYAJIMA N , Maruyama S, Bohgaki M, Kano S, et al
    TRIM68 regulates ligand-dependent transcription of androgen receptor in prostate cancer cells.
    Cancer Res. 2008;68:3486-94.
    PubMed     Related articles    Abstract available
    
    
    
15. PARK SI , Zhang J, Phillips KA, Araujo JC, et al
    Targeting SRC family kinases inhibits growth and lymph node metastases of prostate cancer in an orthotopic nude mouse model.
    Cancer Res. 2008;68:3323-33.
    PubMed     Related articles    Abstract available
    
    
    
16. HERMANS KG , Bressers AA, van der Korput HA, Dits NF, et al
    Two unique novel prostate-specific and androgen-regulated fusion partners of ETV4 in prostate cancer.
    Cancer Res. 2008;68:3094-8.
    PubMed     Related articles    Abstract available
    
    
    
17. SUTHERLAND BW , Knoblaugh SE, Kaplan-Lefko PJ, Wang F, et al
    Conditional deletion of insulin-like growth factor-I receptor in prostate epithelium.
    Cancer Res. 2008;68:3495-504.
    PubMed     Related articles    Abstract available
    
    
    
18. ANZO M , Cobb LJ, Hwang DL, Mehta H, et al
    Targeted deletion of hepatic Igf1 in TRAMP mice leads to dramatic alterations in the circulating insulin-like growth factor axis but does not reduce tumor progression.
    Cancer Res. 2008;68:3342-9.
    PubMed     Related articles    Abstract available
    
    
    April 2008
19. KOBAYASHI N , Barnard RJ, Said J, Hong-Gonzalez J, et al
    Effect of low-fat diet on development of prostate cancer and Akt phosphorylation in the Hi-Myc transgenic mouse model.
    Cancer Res. 2008;68:3066-73.
    PubMed     Related articles    Abstract available
    
    
    
20. HYER ML , Shi R, Krajewska M, Meyer C, et al
    Apoptotic activity and mechanism of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic-acid and related synthetic triterpenoids in prostate cancer.
    Cancer Res. 2008;68:2927-33.
    PubMed     Related articles    Abstract available
    
    
    
21. MAJID S , Kikuno N, Nelles J, Noonan E, et al
    Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification.
    Cancer Res. 2008;68:2736-44.
    PubMed     Related articles    Abstract available
    
    
    
22. WANG LG , Johnson EM, Kinoshita Y, Babb JS, et al
    Androgen receptor overexpression in prostate cancer linked to Pur alpha loss from a novel repressor complex.
    Cancer Res. 2008;68:2678-88.
    PubMed     Related articles    Abstract available
    
    
    
23. EBERT LM , Tan BS, Browning J, Svobodova S, et al
    The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells.
    Cancer Res. 2008;68:3001-9.
    PubMed     Related articles    Abstract available
    
    
    
24. SHOR B , Zhang WG, Toral-Barza L, Lucas J, et al
    A new pharmacologic action of CCI-779 involves FKBP12-independent inhibition of mTOR kinase activity and profound repression of global protein synthesis.
    Cancer Res. 2008;68:2934-43.
    PubMed     Related articles    Abstract available
    
    
    
25. GRAHAM TR , Zhau HE, Odero-Marah VA, Osunkoya AO, et al
    Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells.
    Cancer Res. 2008;68:2479-88.
    PubMed     Related articles    Abstract available
    
    
    
26. KELLY KA , Setlur SR, Ross R, Anbazhagan R, et al
    Detection of early prostate cancer using a hepsin-targeted imaging agent.
    Cancer Res. 2008;68:2286-91.
    PubMed     Related articles    Abstract available
    
    
    
27. REN A , Yan G, You B, Sun J, et al
    Down-regulation of mammalian sterile 20-like kinase 1 by heat shock protein 70 mediates cisplatin resistance in prostate cancer cells.
    Cancer Res. 2008;68:2266-74.
    PubMed     Related articles    Abstract available
    
    
    
28. OUYANG X , Jessen WJ, Al-Ahmadie H, Serio AM, et al
    Activator protein-1 transcription factors are associated with progression and recurrence of prostate cancer.
    Cancer Res. 2008;68:2132-44.
    PubMed     Related articles    Abstract available
    
    
    
29. PEARSON HB , McCarthy A, Collins CM, Ashworth A, et al
    Lkb1 deficiency causes prostate neoplasia in the mouse.
    Cancer Res. 2008;68:2223-32.
    PubMed     Related articles    Abstract available
    
    
    
30. YAMASHITA S , Takahashi S, McDonell N, Watanabe N, et al
    Methylation silencing of transforming growth factor-beta receptor type II in rat prostate cancers.
    Cancer Res. 2008;68:2112-21.
    PubMed     Related articles    Abstract available
    
    
    March 2008
31. LAKSHMAN M , Xu L, Ananthanarayanan V, Cooper J, et al
    Dietary genistein inhibits metastasis of human prostate cancer in mice.
    Cancer Res. 2008;68:2024-32.
    PubMed     Related articles    Abstract available
    
    
    
32. MCCABE CD , Spyropoulos DD, Martin D, Moreno CS, et al
    Genome-wide analysis of the homeobox C6 transcriptional network in prostate cancer.
    Cancer Res. 2008;68:1988-96.
    PubMed     Related articles    Abstract available
    
    
    
33. LI H , Chen X, Calhoun-Davis T, Claypool K, et al
    PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells.
    Cancer Res. 2008;68:1820-5.
    PubMed     Related articles    Abstract available
    
    
    
34. KUMAR B , Koul S, Khandrika L, Meacham RB, et al
    Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype.
    Cancer Res. 2008;68:1777-85.
    PubMed     Related articles    Abstract available
    
    
    
35. JAMIESON WL , Shimizu S, D'Ambrosio JA, Meucci O, et al
    CX3CR1 is expressed by prostate epithelial cells and androgens regulate the levels of CX3CL1/fractalkine in the bone marrow: potential role in prostate cancer bone tropism.
    Cancer Res. 2008;68:1715-22.
    PubMed     Related articles    Abstract available
    
    
    
36. WANG H , Leav I, Ibaragi S, Wegner M, et al
    SOX9 is expressed in human fetal prostate epithelium and enhances prostate cancer invasion.
    Cancer Res. 2008;68:1625-30.
    PubMed     Related articles    Abstract available
    
    
    
37. KONG D , Banerjee S, Huang W, Li Y, et al
    Mammalian target of rapamycin repression by 3,3'-diindolylmethane inhibits invasion and angiogenesis in platelet-derived growth factor-D-overexpressing PC3 cells.
    Cancer Res. 2008;68:1927-34.
    PubMed     Related articles    Abstract available
    
    
    
38. YI T , Yi Z, Cho SG, Luo J, et al
    Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling.
    Cancer Res. 2008;68:1843-50.
    PubMed     Related articles    Abstract available
    
    
    
39. ZHU A , Zhang CX, Lieberman HB
    Rad9 has a functional role in human prostate carcinogenesis.
    Cancer Res. 2008;68:1267-74.
    PubMed     Related articles    Abstract available
    
    
    February 2008
40. VOLOSHYNA I , Besana A, Castillo M, Matos T, et al
    TREK-1 is a novel molecular target in prostate cancer.
    Cancer Res. 2008;68:1197-203.
    PubMed     Related articles    Abstract available
    
    
    
41. LU M , Xia L, Hua H, Jing Y, et al
    Acetyl-keto-beta-boswellic acid induces apoptosis through a death receptor 5-mediated pathway in prostate cancer cells.
    Cancer Res. 2008;68:1180-6.
    PubMed     Related articles    Abstract available
    
    
    
42. HARA T , Miyazaki H, Lee A, Tran CP, et al
    Androgen receptor and invasion in prostate cancer.
    Cancer Res. 2008;68:1128-35.
    PubMed     Related articles    Abstract available
    
    
    
43. NAJY AJ , Day KC, Day ML
    ADAM15 supports prostate cancer metastasis by modulating tumor cell-endothelial cell interaction.
    Cancer Res. 2008;68:1092-9.
    PubMed     Related articles    Abstract available
    
    
    
44. GRAVES CW , Philips ST, Bradley SV, Oravecz-Wilson KI, et al
    Use of a cryptic splice site for the expression of huntingtin interacting protein 1 in select normal and neoplastic tissues.
    Cancer Res. 2008;68:1064-73.
    PubMed     Related articles    Abstract available
    
    
    
45. WALLACE TA , Prueitt RL, Yi M, Howe TM, et al
    Tumor immunobiological differences in prostate cancer between African-American and European-American men.
    Cancer Res. 2008;68:927-36.
    PubMed     Related articles    Abstract available
    
    
    
46. GARCIA-HERNANDEZ MDE L , Gray A, Hubby B, Klinger OJ, et al
    Prostate stem cell antigen vaccination induces a long-term protective immune response against prostate cancer in the absence of autoimmunity.
    Cancer Res. 2008;68:861-9.
    PubMed     Related articles    Abstract available
    
    
    
47. TAHIR SA , Yang G, Goltsov AA, Watanabe M, et al
    Tumor cell-secreted caveolin-1 has proangiogenic activities in prostate cancer.
    Cancer Res. 2008;68:731-9.
    PubMed     Related articles    Abstract available
    
    
    
48. LAXMAN B , Morris DS, Yu J, Siddiqui J, et al
    A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer.
    Cancer Res. 2008;68:645-9.
    PubMed     Related articles    Abstract available
    
    
    
49. ARAP W , Trepel M, Zetter BR, Pasqualini R, et al
    Meeting report: innovations in prostate cancer research.
    Cancer Res. 2008;68:635-8.
    PubMed     Related articles   
    
    
    January 2008
50. EBOS JM , Lee CR, Bogdanovic E, Alami J, et al
    Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth.
    Cancer Res. 2008;68:521-9.
    PubMed     Related articles    Abstract available
    
    
    
51. SARFARAZ S , Adhami VM, Syed DN, Afaq F, et al
    Cannabinoids for cancer treatment: progress and promise.
    Cancer Res. 2008;68:339-42.
    PubMed     Related articles    Abstract available
    
    
    
52. DEGL'INNOCENTI E , Grioni M, Capuano G, Jachetti E, et al
    Peripheral T-cell tolerance associated with prostate cancer is independent from CD4+CD25+ regulatory T cells.
    Cancer Res. 2008;68:292-300.
    PubMed     Related articles    Abstract available
    
    
    
53. TAN SH , Dagvadorj A, Shen F, Gu L, et al
    Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells.
    Cancer Res. 2008;68:236-48.
    PubMed     Related articles    Abstract available
    
    
    
54. YANG S , Pham LK, Liao CP, Frenkel B, et al
    A novel bone morphogenetic protein signaling in heterotypic cell interactions in prostate cancer.
    Cancer Res. 2008;68:198-205.
    PubMed     Related articles    Abstract available
    
    
    
55. GLUNDE K , Shah T, Winnard PT Jr, Raman V, et al
    Hypoxia regulates choline kinase expression through hypoxia-inducible factor-1 alpha signaling in a human prostate cancer model.
    Cancer Res. 2008;68:172-80.
    PubMed     Related articles    Abstract available
    
    
    
56. NIE D , Guo Y, Yang D, Tang Y, et al
    Thromboxane A2 receptors in prostate carcinoma: expression and its role in regulating cell motility via small GTPase Rho.
    Cancer Res. 2008;68:115-21.
    PubMed     Related articles    Abstract available
    
    
    
57. HELGESON BE , Tomlins SA, Shah N, Laxman B, et al
    Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer.
    Cancer Res. 2008;68:73-80.
    PubMed     Related articles    Abstract available
    
    
    December 2007
58. KOTTKE T , Sanchez-Perez L, Diaz RM, Thompson J, et al
    Induction of hsp70-mediated Th17 autoimmunity can be exploited as immunotherapy for metastatic prostate cancer.
    Cancer Res. 2007;67:11970-9.
    PubMed     Related articles    Abstract available
    
    
    
59. GRAY PJ JR , Stevenson MA, Calderwood SK
    Targeting Cdc37 inhibits multiple signaling pathways and induces growth arrest in prostate cancer cells.
    Cancer Res. 2007;67:11942-50.
    PubMed     Related articles    Abstract available
    
    
    
60. GANGULY A , Das B, Roy A, Sen N, et al
    Betulinic acid, a catalytic inhibitor of topoisomerase I, inhibits reactive oxygen species-mediated apoptotic topoisomerase I-DNA cleavable complex formation in prostate cancer cells but does not affect the process of cell death.
    Cancer Res. 2007;67:11848-58.
    PubMed     Related articles    Abstract available
    
    
    
61. O'CALLAGHAN-SUNOL C , Gabai VL, Sherman MY
    Hsp27 modulates p53 signaling and suppresses cellular senescence.
    Cancer Res. 2007;67:11779-88.
    PubMed     Related articles    Abstract available
    
    
    
62. QUANN EJ , Khwaja F, Djakiew D
    The p38 MAPK pathway mediates aryl propionic acid induced messenger rna stability of p75 NTR in prostate cancer cells.
    Cancer Res. 2007;67:11402-10.
    PubMed     Related articles    Abstract available
    
    
    
63. CRETON SK , Zhu H, Gooderham NJ
    The cooked meat carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine activates the extracellular signal regulated kinase mitogen-activated protein kinase pathway.
    Cancer Res. 2007;67:11455-62.
    PubMed     Related articles    Abstract available
    
    
    
64. GARRISON JB , Shaw YJ, Chen CS, Kyprianou N, et al
    Novel quinazoline-based compounds impair prostate tumorigenesis by targeting tumor vascularity.
    Cancer Res. 2007;67:11344-52.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    November 2007
65. VILLAR J , Arenas MI, Maccarthy CM, Blanquez MJ, et al
    PCPH/ENTPD5 Expression Enhances the Invasiveness of Human Prostate Cancer Cells by a Protein Kinase C{delta} Dependent Mechanism.
    Cancer Res. 2007;67:10859-10868.
    PubMed     Related articles    Abstract available
    
    
    
66. YU J , Yu J, Rhodes DR, Tomlins SA, et al
    A Polycomb Repression Signature in Metastatic Prostate Cancer Predicts Cancer Outcome.
    Cancer Res. 2007;67:10657-10663.
    PubMed     Related articles    Abstract available
    
    
    
67. RAINA K , Blouin MJ, Singh RP, Majeed N, et al
    Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model.
    Cancer Res. 2007;67:11083-91.
    PubMed     Related articles    Abstract available
    
    
    
68. KAWAKUBO T , Okamoto K, Iwata J, Shin M, et al
    Cathepsin E prevents tumor growth and metastasis by catalyzing the proteolytic release of soluble TRAIL from tumor cell surface.
    Cancer Res. 2007;67:10869-78.
    PubMed     Related articles    Abstract available
    
    
    
69. THIYAGARAJAN S , Bhatia N, Reagan-Shaw S, Cozma D, et al
    Role of GLI2 transcription factor in growth and tumorigenicity of prostate cells.
    Cancer Res. 2007;67:10642-6.
    PubMed     Related articles    Abstract available
    
    
    
70. HEEMERS HV , Regan KM, Dehm SM, Tindall DJ, et al
    Androgen Induction of the Androgen Receptor Coactivator Four and a Half LIM Domain Protein-2: Evidence for a Role for Serum Response Factor in Prostate Cancer.
    Cancer Res. 2007;67:10592-10599.
    PubMed     Related articles    Abstract available
    
    
    
71. CHEN Y , Tang Y, Wang MT, Zeng S, et al
    Human Pregnane X Receptor and Resistance to Chemotherapy in Prostate Cancer.
    Cancer Res. 2007;67:10361-10367.
    PubMed     Related articles    Abstract available
    
    
    
72. SETLUR SR , Royce TE, Sboner A, Mosquera JM, et al
    Integrative Microarray Analysis of Pathways Dysregulated in Metastatic Prostate Cancer.
    Cancer Res. 2007;67:10296-10303.
    PubMed     Related articles    Abstract available
    
    
    
73. ANDREANI V , Gatti G, Simonella L, Rivero V, et al
    Activation of Toll-like receptor 4 on tumor cells in vitro inhibits subsequent tumor growth in vivo.
    Cancer Res. 2007;67:10519-27.
    PubMed     Related articles    Abstract available
    
    
    
74. ZOUBEIDI A , Zardan A, Beraldi E, Fazli L, et al
    Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity.
    Cancer Res. 2007;67:10455-65.
    PubMed     Related articles    Abstract available
    
    
    
75. SVENSSON RU , Barnes JM, Rokhlin OW, Cohen MB, et al
    Chemotherapeutic agents up-regulate the cytomegalovirus promoter: implications for bioluminescence imaging of tumor response to therapy.
    Cancer Res. 2007;67:10445-54.
    PubMed     Related articles    Abstract available
    
    
    
76. MORETTI RM , Marelli MM, Mai S, Cariboni A, et al
    Clusterin isoforms differentially affect growth and motility of prostate cells: possible implications in prostate tumorigenesis.
    Cancer Res. 2007;67:10325-33.
    PubMed     Related articles    Abstract available
    
    
    October 2007
77. BUCHANAN G , Ricciardelli C, Harris JM, Prescott J, et al
    Control of Androgen Receptor Signaling in Prostate Cancer by the Cochaperone Small Glutamine Rich Tetratricopeptide Repeat Containing Protein {alpha}.
    Cancer Res. 2007;67:10087-96.
    PubMed     Related articles    Abstract available
    
    
    
78. DEHM SM , Regan KM, Schmidt LJ, Tindall DJ, et al
    Selective Role of an NH2-Terminal WxxLF Motif for Aberrant Androgen Receptor Activation in Androgen Depletion Independent Prostate Cancer Cells.
    Cancer Res. 2007;67:10067-77.
    PubMed     Related articles    Abstract available
    
    
    
79. SALAH Z , Maoz M, Pizov G, Bar-Shavit R, et al
    Transcriptional regulation of human protease-activated receptor 1: a role for the early growth response-1 protein in prostate cancer.
    Cancer Res. 2007;67:9835-43.
    PubMed     Related articles    Abstract available
    
    
    
80. FENTON BM , Paoni SF
    The addition of AG-013736 to fractionated radiation improves tumor response without functionally normalizing the tumor vasculature.
    Cancer Res. 2007;67:9921-8.
    PubMed     Related articles    Abstract available
    
    
    
81. STATHOPOULOS GT , Kollintza A, Moschos C, Psallidas I, et al
    Tumor necrosis factor-alpha promotes malignant pleural effusion.
    Cancer Res. 2007;67:9825-34.
    PubMed     Related articles    Abstract available
    
    
    
82. KELLER ET , Rowley DR, Tomlins SA, Drake CG, et al
    Eleventh Prouts Neck Meeting on Prostate Cancer: Emerging Strategies in Prostate Cancer Therapy.
    Cancer Res. 2007;.
    PubMed     Related articles   
    
    
    
83. ZHANG X , Zhang L, Yang H, Huang X, et al
    c-Fos as a Proapoptotic Agent in TRAIL-Induced Apoptosis in Prostate Cancer Cells.
    Cancer Res. 2007;67:9425-34.
    PubMed     Related articles    Abstract available
    
    
    
84. LOBERG RD , Ying C, Craig M, Day LL, et al
    Targeting CCL2 with Systemic Delivery of Neutralizing Antibodies Induces Prostate Cancer Tumor Regression In vivo.
    Cancer Res. 2007;67:9417-24.
    PubMed     Related articles    Abstract available
    
    
    
85. VARGHESE S , Rabkin SD, Nielsen GP, Macgarvey U, et al
    Systemic therapy of spontaneous prostate cancer in transgenic mice with oncolytic herpes simplex viruses.
    Cancer Res. 2007;67:9371-9.
    PubMed     Related articles    Abstract available
    
    
    
86. KLEEBERGER W , Bova GS, Nielsen ME, Herawi M, et al
    Roles for the stem cell associated intermediate filament nestin in prostate cancer migration and metastasis.
    Cancer Res. 2007;67:9199-206.
    PubMed     Related articles    Abstract available
    
    
    
87. BANACH-PETROSKY W , Jessen WJ, Ouyang X, Gao H, et al
    Prolonged Exposure to Reduced Levels of Androgen Accelerates Prostate Cancer Progression in Nkx3.1; Pten Mutant Mice.
    Cancer Res. 2007;67:9089-9096.
    PubMed     Related articles    Abstract available
    
    
    
88. IMAI M , Ohta R, Varela JC, Song H, et al
    Enhancement of antibody-dependent mechanisms of tumor cell lysis by a targeted activator of complement.
    Cancer Res. 2007;67:9535-41.
    PubMed     Related articles    Abstract available
    
    
    
89. ZHANG Y , Bressler JP, Neal J, Lal B, et al
    ABCG2/BCRP expression modulates D-Luciferin based bioluminescence imaging.
    Cancer Res. 2007;67:9389-97.
    PubMed     Related articles    Abstract available
    
    
    
90. PARK SY , Yu X, Ip C, Mohler JL, et al
    Peroxiredoxin 1 interacts with androgen receptor and enhances its transactivation.
    Cancer Res. 2007;67:9294-303.
    PubMed     Related articles    Abstract available
    
    
    
91. CHEN D , Frezza M, Shakya R, Cui QC, et al
    Inhibition of the proteasome activity by gallium(III) complexes contributes to their anti prostate tumor effects.
    Cancer Res. 2007;67:9258-65.
    PubMed     Related articles    Abstract available
    
    
    
92. LIBERTINI SJ , Tepper CG, Rodriguez V, Asmuth DM, et al
    Evidence for calpain-mediated androgen receptor cleavage as a mechanism for androgen independence.
    Cancer Res. 2007;67:9001-5.
    PubMed     Related articles    Abstract available
    
    
    September 2007
93. PANDINI G , Genua M, Frasca F, Squatrito S, et al
    17{beta}-Estradiol Up-regulates the Insulin-like Growth Factor Receptor through a Nongenotropic Pathway in Prostate Cancer Cells.
    Cancer Res. 2007;67:8932-41.
    PubMed     Related articles    Abstract available
    
    
    
94. ZHANG H , Wang J, Pang B, Liang RX, et al
    PC-1/PrLZ Contributes to Malignant Progression in Prostate Cancer.
    Cancer Res. 2007;67:8906-13.
    PubMed     Related articles    Abstract available
    
    
    
95. AZIZ MH , Manoharan HT, Church DR, Dreckschmidt NE, et al
    Protein Kinase C{varepsilon} Interacts with Signal Transducers and Activators of Transcription 3 (Stat3), Phosphorylates Stat3Ser727, and Regulates Its Constitutive Activation in Prostate Cancer.
    Cancer Res. 2007;67:8828-38.
    PubMed     Related articles    Abstract available
    
    
    
96. LAPOINTE J , Li C, Giacomini CP, Salari K, et al
    Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis.
    Cancer Res. 2007;67:8504-10.
    PubMed     Related articles    Abstract available
    
    
    
97. HUDSON TS , Hartle DK, Hursting SD, Nunez NP, et al
    Inhibition of Prostate Cancer Growth by Muscadine Grape Skin Extract and Resveratrol through Distinct Mechanisms.
    Cancer Res. 2007;67:8396-405.
    PubMed     Related articles    Abstract available
    
    
    
98. HODGSON MC , Astapova I, Hollenberg AN, Balk SP, et al
    Activity of Androgen Receptor Antagonist Bicalutamide in Prostate Cancer Cells Is Independent of NCoR and SMRT Corepressors.
    Cancer Res. 2007;67:8388-95.
    PubMed     Related articles    Abstract available
    
    
    
99. CASAREZ EV , Dunlap-Brown ME, Conaway MR, Amorino GP, et al
    Radiosensitization and Modulation of p44/42 Mitogen-Activated Protein Kinase by 2-Methoxyestradiol in Prostate Cancer Models.
    Cancer Res. 2007;67:8316-24.
    PubMed     Related articles    Abstract available
    
    
    
100. KIM JH , Dhanasekaran SM, Mehra R, Tomlins SA, et al
     Integrative analysis of genomic aberrations associated with prostate cancer progression.
     Cancer Res. 2007;67:8229-39.
     PubMed     Related articles    Abstract available
     
     
     
101. HE Y , Franco OE, Jiang M, Williams K, et al
     Tissue-Specific Consequences of Cyclin D1 Overexpression in Prostate Cancer Progression.
     Cancer Res. 2007;67:8188-8197.
     PubMed     Related articles    Abstract available
     
     
     
102. YU YP , Yu G, Tseng G, Cieply K, et al
     Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis.
     Cancer Res. 2007;67:8043-50.
     PubMed     Related articles    Abstract available
     
     
     
103. MAWJI IA , Simpson CD, Gronda M, Williams MA, et al
     A chemical screen identifies anisomycin as an anoikis sensitizer that functions by decreasing FLIP protein synthesis.
     Cancer Res. 2007;67:8307-15.
     PubMed     Related articles    Abstract available
     
     
     
104. BECKERS A , Organe S, Timmermans L, Scheys K, et al
     Chemical inhibition of acetyl-CoA carboxylase induces growth arrest and cytotoxicity selectively in cancer cells.
     Cancer Res. 2007;67:8180-7.
     PubMed     Related articles    Abstract available
     
     
     
105. DEEB KK , Michalowska AM, Yoon CY, Krummey SM, et al
     Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis.
     Cancer Res. 2007;67:8065-80.
     PubMed     Related articles    Abstract available
     
     
     
106. NAKAHARA T , Takeuchi M, Kinoyama I, Minematsu T, et al
     YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts.
     Cancer Res. 2007;67:8014-21.
     PubMed     Related articles    Abstract available
     
     
     
107. MEHRA R , Han B, Tomlins SA, Wang L, et al
     Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases.
     Cancer Res. 2007;67:7991-5.
     PubMed     Related articles    Abstract available
     
     
     August 2007
108. WENG JR , Tsai CH, Kulp SK, Wang D, et al
     A potent indole-3-carbinol derived antitumor agent with pleiotropic effects on multiple signaling pathways in prostate cancer cells.
     Cancer Res. 2007;67:7815-24.
     PubMed     Related articles    Abstract available
     
     
     
109. KASEB AO , Chinnakannu K, Chen D, Sivanandam A, et al
     Androgen Receptor and E2F-1 Targeted Thymoquinone Therapy for Hormone-Refractory Prostate Cancer.
     Cancer Res. 2007;67:7782-8.
     PubMed     Related articles    Abstract available
     
     
     
110. MUKHOPADHAYA A , Mendecki J, Dong X, Liu L, et al
     Localized hyperthermia combined with intratumoral dendritic cells induces systemic antitumor immunity.
     Cancer Res. 2007;67:7798-806.
     PubMed     Related articles    Abstract available
     
     
     
111. ROTH TJ , Sheinin Y, Lohse CM, Kuntz SM, et al
     B7-H3 Ligand Expression by Prostate Cancer: A Novel Marker of Prognosis and Potential Target for Therapy.
     Cancer Res. 2007;.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
112. DIELI F , Vermijlen D, Fulfaro F, Caccamo N, et al
     Targeting Human {gamma}{delta} T Cells with Zoledronate and Interleukin-2 for Immunotherapy of Hormone-Refractory Prostate Cancer.
     Cancer Res. 2007;67:7450-7.
     PubMed     Related articles    Abstract available
     
     
     
113. SINGH SV , Choi S, Zeng Y, Hahm ER, et al
     Guggulsterone-Induced Apoptosis in Human Prostate Cancer Cells Is Caused by Reactive Oxygen Intermediate Dependent Activation of c-Jun NH2-Terminal Kinase.
     Cancer Res. 2007;67:7439-49.
     PubMed     Related articles    Abstract available
     
     
     
114. LIAO CP , Zhong C, Saribekyan G, Bading J, et al
     Mouse models of prostate adenocarcinoma with the capacity to monitor spontaneous carcinogenesis by bioluminescence or fluorescence.
     Cancer Res. 2007;67:7525-33.
     PubMed     Related articles    Abstract available
     
     
     
115. CLAYTON A , Mitchell JP, Court J, Mason MD, et al
     Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2.
     Cancer Res. 2007;67:7458-66.
     PubMed     Related articles    Abstract available
     
     
     July 2007
116. ARAKI S , Omori Y, Lyn D, Singh RK, et al
     Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer.
     Cancer Res. 2007;67:6854-62.
     PubMed     Related articles    Abstract available
     
     
     
117. PATRAWALA L , Calhoun-Davis T, Schneider-Broussard R, Tang DG, et al
     Hierarchical Organization of Prostate Cancer Cells in Xenograft Tumors: The CD44+{alpha}2{beta}1+ Cell Population Is Enriched in Tumor-Initiating Cells.
     Cancer Res. 2007;67:6796-805.
     PubMed     Related articles    Abstract available
     
     
     
118. HUFFMAN DM , Grizzle WE, Bamman MM, Kim JS, et al
     SIRT1 Is Significantly Elevated in Mouse and Human Prostate Cancer.
     Cancer Res. 2007;67:6612-8.
     PubMed     Related articles    Abstract available
     
     
     
119. CHEN N , Ye XC, Chu K, Navone NM, et al
     A Secreted Isoform of ErbB3 Promotes Osteonectin Expression in Bone and Enhances the Invasiveness of Prostate Cancer Cells.
     Cancer Res. 2007;67:6544-8.
     PubMed     Related articles    Abstract available
     
     
     
120. SHEN MM , Abate-Shen C
     Pten inactivation and the emergence of androgen-independent prostate cancer.
     Cancer Res. 2007;67:6535-8.
     PubMed     Related articles    Abstract available
     
     
     
121. SHUKLA S , MacLennan GT, Flask CA, Fu P, et al
     Blockade of beta-catenin signaling by plant flavonoid apigenin suppresses prostate carcinogenesis in TRAMP mice.
     Cancer Res. 2007;67:6925-35.
     PubMed     Related articles    Abstract available
     
     
     
122. PULUKURI SM , Rao JS
     Small interfering RNA directed reversal of urokinase plasminogen activator demethylation inhibits prostate tumor growth and metastasis.
     Cancer Res. 2007;67:6637-46.
     PubMed     Related articles    Abstract available
     
     
     
123. REGE K , Patel SJ, Megeed Z, Yarmush ML, et al
     Amphipathic peptide-based fusion peptides and immunoconjugates for the targeted ablation of prostate cancer cells.
     Cancer Res. 2007;67:6368-75.
     PubMed     Related articles    Abstract available
     
     
     
124. DAN HC , Adli M, Baldwin AS
     Regulation of mammalian target of rapamycin activity in PTEN-inactive prostate cancer cells by I kappa B kinase alpha.
     Cancer Res. 2007;67:6263-9.
     PubMed     Related articles    Abstract available
     
     
     
125. SHARMA A , Comstock CE, Knudsen ES, Cao KH, et al
     Retinoblastoma tumor suppressor status is a critical determinant of therapeutic response in prostate cancer cells.
     Cancer Res. 2007;67:6192-203.
     PubMed     Related articles    Abstract available
     
     
     
126. SIZEMORE S , Cicek M, Sizemore N, Ng KP, et al
     Podocalyxin increases the aggressive phenotype of breast and prostate cancer cells in vitro through its interaction with ezrin.
     Cancer Res. 2007;67:6183-91.
     PubMed     Related articles    Abstract available
     
     
     
127. VALENZUELA HF , Pace KE, Cabrera PV, White R, et al
     O-glycosylation regulates LNCaP prostate cancer cell susceptibility to apoptosis induced by galectin-1.
     Cancer Res. 2007;67:6155-62.
     PubMed     Related articles    Abstract available
     
     
     
128. PORKKA KP , Pfeiffer MJ, Waltering KK, Vessella RL, et al
     MicroRNA expression profiling in prostate cancer.
     Cancer Res. 2007;67:6130-5.
     PubMed     Related articles    Abstract available
     
     
     
129. JIAO J , Wang S, Qiao R, Vivanco I, et al
     Murine cell lines derived from Pten null prostate cancer show the critical role of PTEN in hormone refractory prostate cancer development.
     Cancer Res. 2007;67:6083-91.
     PubMed     Related articles    Abstract available
     
     
     
130. MILOSEVIC M , Chung P, Parker C, Bristow R, et al
     Androgen withdrawal in patients reduces prostate cancer hypoxia: implications for disease progression and radiation response.
     Cancer Res. 2007;67:6022-5.
     PubMed     Related articles    Abstract available
     
     
     
131. ADAM RM , Mukhopadhyay NK, Kim J, Di Vizio D, et al
     Cholesterol sensitivity of endogenous and myristoylated Akt.
     Cancer Res. 2007;67:6238-46.
     PubMed     Related articles    Abstract available
     
     
     June 2007
132. CHUNG AC , Zhou S, Liao L, Tien JC, et al
     Genetic Ablation of the Amplified-in-Breast Cancer 1 Inhibits Spontaneous Prostate Cancer Progression in Mice.
     Cancer Res. 2007;67:5965-75.
     PubMed     Related articles    Abstract available
     
     
     
133. ISAYEVA T , Chanda D, Kallman L, Eltoum IE, et al
     Effects of Sustained Antiangiogenic Therapy in Multistage Prostate Cancer in TRAMP Model.
     Cancer Res. 2007;67:5789-97.
     PubMed     Related articles    Abstract available
     
     
     
134. LIU XH , Kirschenbaum A, Yao S, Liu G, et al
     Androgen-Induced Wnt Signaling in Preosteoblasts Promotes the Growth of MDA-PCa-2b Human Prostate Cancer Cells.
     Cancer Res. 2007;67:5747-53.
     PubMed     Related articles    Abstract available
     
     
     
135. VERONA EV , Elkahloun AG, Yang J, Bandyopadhyay A, et al
     Transforming Growth Factor-{beta} Signaling in Prostate Stromal Cells Supports Prostate Carcinoma Growth by Up-regulating Stromal Genes Related to Tissue Remodeling.
     Cancer Res. 2007;67:5737-46.
     PubMed     Related articles    Abstract available
     
     
     
136. RAINA K , Singh RP, Agarwal R, Agarwal C, et al
     Oral grape seed extract inhibits prostate tumor growth and progression in TRAMP mice.
     Cancer Res. 2007;67:5976-82.
     PubMed     Related articles    Abstract available
     
     
     
137. ZHANG L , Gao L, Zhao L, Guo B, et al
     Intratumoral delivery and suppression of prostate tumor growth by attenuated Salmonella enterica serovar typhimurium carrying plasmid-based small interfering RNAs.
     Cancer Res. 2007;67:5859-64.
     PubMed     Related articles    Abstract available
     
     
     
138. CHALLITA-EID PM , Morrison K, Etessami S, An Z, et al
     Monoclonal antibodies to six-transmembrane epithelial antigen of the prostate-1 inhibit intercellular communication in vitro and growth of human tumor xenografts in vivo.
     Cancer Res. 2007;67:5798-805.
     PubMed     Related articles    Abstract available
     
     
     
139. ZHOU Z , Flesken-Nikitin A, Nikitin AY
     Prostate Cancer Associated with p53 and Rb Deficiency Arises from the Stem/Progenitor Cell-Enriched Proximal Region of Prostatic Ducts.
     Cancer Res. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
140. CHEN CS , Wang YC, Yang HC, Huang PH, et al
     Histone Deacetylase Inhibitors Sensitize Prostate Cancer Cells to Agents that Produce DNA Double-Strand Breaks by Targeting Ku70 Acetylation.
     Cancer Res. 2007;67:5318-27.
     PubMed     Related articles    Abstract available
     
     
     
141. KLOKK TI , Kilander A, Xi Z, Waehre H, et al
     Kallikrein 4 Is a Proliferative Factor that Is Overexpressed in Prostate Cancer.
     Cancer Res. 2007;67:5221-5230.
     PubMed     Related articles    Abstract available
     
     
     
142. TAMURA K , Furihata M, Tsunoda T, Ashida S, et al
     Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles.
     Cancer Res. 2007;67:5117-25.
     PubMed     Related articles    Abstract available
     
     
     
143. KOBAYASHI H , Nagato T, Sato K, Aoki N, et al
     Recognition of Prostate and Melanoma Tumor Cells by Six-Transmembrane Epithelial Antigen of Prostate-Specific Helper T Lymphocytes in a Human Leukocyte Antigen Class II-Restricted Manner.
     Cancer Res. 2007;67:5498-504.
     PubMed     Related articles    Abstract available
     
     
     
144. SARKAR D , Lebedeva IV, Su ZZ, Park ES, et al
     Eradication of therapy-resistant human prostate tumors using a cancer terminator virus.
     Cancer Res. 2007;67:5434-42.
     PubMed     Related articles    Abstract available
     
     
     May 2007
145. MOSTAGHEL EA , Page ST, Lin DW, Fazli L, et al
     Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer.
     Cancer Res. 2007;67:5033-41.
     PubMed     Related articles    Abstract available
     
     
     
146. YU S , Wang X, Ng CF, Chen S, et al
     ERR{gamma} Suppresses Cell Proliferation and Tumor Growth of Androgen-Sensitive and Androgen-Insensitive Prostate Cancer Cells and Its Implication as a Therapeutic Target for Prostate Cancer.
     Cancer Res. 2007;67:4904-14.
     PubMed     Related articles    Abstract available
     
     
     
147. GU G , Yuan J, Wills M, Kasper S, et al
     Prostate Cancer Cells with Stem Cell Characteristics Reconstitute the Original Human Tumor In vivo.
     Cancer Res. 2007;67:4807-15.
     PubMed     Related articles    Abstract available
     
     
     
148. TILLMAN JE , Yuan J, Gu G, Fazli L, et al
     DJ-1 Binds Androgen Receptor Directly and Mediates Its Activity in Hormonally Treated Prostate Cancer Cells.
     Cancer Res. 2007;67:4630-7.
     PubMed     Related articles    Abstract available
     
     
     
149. REICHARDT JK , Tilley WD
     The 3rd pacific rim meeting on breast and prostate cancer: progress in hormonal carcinogenesis and the enduring influence of ron ross.
     Cancer Res. 2007;67:4550-2.
     PubMed     Related articles   
     
     
     
150. GU X , Zerbini LF, Otu HH, Bhasin M, et al
     Reduced PDEF Expression Increases Invasion and Expression of Mesenchymal Genes in Prostate Cancer Cells.
     Cancer Res. 2007;67:4219-26.
     PubMed     Related articles    Abstract available
     
     
     
151. CHANG BL , Liu W, Sun J, Dimitrov L, et al
     Integration of somatic deletion analysis of prostate cancers and germline linkage analysis of prostate cancer families reveals two small consensus regions for prostate cancer genes at 8p.
     Cancer Res. 2007;67:4098-103.
     PubMed     Related articles    Abstract available
     
     
     
152. VIJAYVARGIA R , May MS, Fondell JD
     A Coregulatory Role for the Mediator Complex in Prostate Cancer Cell Proliferation and Gene Expression.
     Cancer Res. 2007;67:4034-4041.
     PubMed     Related articles    Abstract available
     
     
     
153. HAELENS A , Tanner T, Denayer S, Callewaert L, et al
     The hinge region regulates DNA binding, nuclear translocation, and transactivation of the androgen receptor.
     Cancer Res. 2007;67:4514-23.
     PubMed     Related articles    Abstract available
     
     
     
154. GANESH S , Gonzalez Edick M, Idamakanti N, Abramova M, et al
     Relaxin-expressing, fiber chimeric oncolytic adenovirus prolongs survival of tumor-bearing mice.
     Cancer Res. 2007;67:4399-407.
     PubMed     Related articles    Abstract available
     
     
     
155. CASIMIRO M , Rodriguez O, Pootrakul L, Aventian M, et al
     ErbB-2 induces the cyclin D1 gene in prostate epithelial cells in vitro and in vivo.
     Cancer Res. 2007;67:4364-72.
     PubMed     Related articles    Abstract available
     
     
     
156. AO M , Franco OE, Park D, Raman D, et al
     Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.
     Cancer Res. 2007;67:4244-53.
     PubMed     Related articles    Abstract available
     
     
     April 2007
157. BANERJEE S , Hussain M, Wang Z, Saliganan A, et al
     In vitro and In vivo Molecular Evidence for Better Therapeutic Efficacy of ABT-627 and Taxotere Combination in Prostate Cancer.
     Cancer Res. 2007;67:3818-26.
     PubMed     Related articles    Abstract available
     
     
     
158. DEEBLE PD , Cox ME, Frierson HF Jr, Sikes RA, et al
     Androgen-Independent Growth and Tumorigenesis of Prostate Cancer Cells Are Enhanced by the Presence of PKA-Differentiated Neuroendocrine Cells.
     Cancer Res. 2007;67:3663-72.
     PubMed     Related articles    Abstract available
     
     
     
159. LU Y , Cai Z, Xiao G, Keller ET, et al
     Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption.
     Cancer Res. 2007;67:3646-53.
     PubMed     Related articles    Abstract available
     
     
     
160. LEE KC , Sud S, Meyer CR, Moffat BA, et al
     An Imaging Biomarker of Early Treatment Response in Prostate Cancer that Has Metastasized to the Bone.
     Cancer Res. 2007;67:3524-8.
     PubMed     Related articles    Abstract available
     
     
     
161. TSAI MH , Cook JA, Chandramouli GV, Degraff W, et al
     Gene Expression Profiling of Breast, Prostate, and Glioma Cells following Single versus Fractionated Doses of Radiation.
     Cancer Res. 2007;67:3845-52.
     PubMed     Related articles    Abstract available
     
     
     
162. CHOI KJ , Piao YJ, Lim MJ, Kim JH, et al
     Overexpressed cyclophilin A in cancer cells renders resistance to hypoxia- and cisplatin-induced cell death.
     Cancer Res. 2007;67:3654-62.
     PubMed     Related articles    Abstract available
     
     
     
163. HEEMERS HV , Sebo TJ, Debes JD, Regan KM, et al
     Androgen Deprivation Increases p300 Expression in Prostate Cancer Cells.
     Cancer Res. 2007;67:3422-30.
     PubMed     Related articles    Abstract available
     
     
     
164. KONG D , Li Y, Wang Z, Banerjee S, et al
     Inhibition of Angiogenesis and Invasion by 3,3'-Diindolylmethane Is Mediated by the Nuclear Factor-{kappa}B Downstream Target Genes MMP-9 and uPA that Regulated Bioavailability of Vascular Endothelial Growth Factor in Prostate Cancer.
     Cancer Res. 2007;67:3310-9.
     PubMed     Related articles    Abstract available
     
     
     
165. MIKI J , Furusato B, Li H, Gu Y, et al
     Identification of Putative Stem Cell Markers, CD133 and CXCR4, in hTERT-Immortalized Primary Nonmalignant and Malignant Tumor-Derived Human Prostate Epithelial Cell Lines and in Prostate Cancer Specimens.
     Cancer Res. 2007;67:3153-61.
     PubMed     Related articles    Abstract available
     
     
     
166. WANG L , McDonnell SK, Slusser JP, Hebbring SJ, et al
     Two common chromosome 8q24 variants are associated with increased risk for prostate cancer.
     Cancer Res. 2007;67:2944-50.
     PubMed     Related articles    Abstract available
     
     
     
167. PLATZ EA
     Genetic variation at 8q24 as a susceptibility factor for prostate cancer: definitive results from epidemiologic studies?
     Cancer Res. 2007;67:2905-7.
     PubMed     Related articles   
     
     
     
168. QUANN EJ , Khwaja F, Zavitz KH, Djakiew D, et al
     The aryl propionic acid R-flurbiprofen selectively induces p75NTR-dependent decreased survival of prostate tumor cells.
     Cancer Res. 2007;67:3254-62.
     PubMed     Related articles    Abstract available
     
     
     
169. YANG CC , Wang YC, Wei S, Lin LF, et al
     Peroxisome proliferator-activated receptor gamma-independent suppression of androgen receptor expression by troglitazone mechanism and pharmacologic exploitation.
     Cancer Res. 2007;67:3229-38.
     PubMed     Related articles    Abstract available
     
     
     
170. SCHUMACHER FR , Feigelson HS, Cox DG, Haiman CA, et al
     A Common 8q24 Variant in Prostate and Breast Cancer from a Large Nested Case-Control Study.
     Cancer Res. 2007;67:2951-2956.
     PubMed     Related articles    Abstract available
     
     
     March 2007
171. MURPHY AJ , Hughes CA, Barrett C, Magee H, et al
     Low-Level TOP2A Amplification in Prostate Cancer Is Associated with HER2 Duplication, Androgen Resistance, and Decreased Survival.
     Cancer Res. 2007;67:2893-8.
     PubMed     Related articles    Abstract available
     
     
     
172. XUAN JW , Bygrave M, Jiang H, Valiyeva F, et al
     Functional neoangiogenesis imaging of genetically engineered mouse prostate cancer using three-dimensional power Doppler ultrasound.
     Cancer Res. 2007;67:2830-9.
     PubMed     Related articles    Abstract available
     
     
     
173. CHINTHARLAPALLI S , Papineni S, Ramaiah SK, Safe S, et al
     Betulinic Acid Inhibits Prostate Cancer Growth through Inhibition of Specificity Protein Transcription Factors.
     Cancer Res. 2007;67:2816-23.
     PubMed     Related articles    Abstract available
     
     
     
174. BRUXVOORT KJ , Charbonneau HM, Giambernardi TA, Goolsby JC, et al
     Inactivation of apc in the mouse prostate causes prostate carcinoma.
     Cancer Res. 2007;67:2490-6.
     PubMed     Related articles    Abstract available
     
     
     
175. LI W , Zhang X, Olumi AF
     MG-132 Sensitizes TRAIL-Resistant Prostate Cancer Cells by Activating c-Fos/c-Jun Heterodimers and Repressing c-FLIP(L).
     Cancer Res. 2007;67:2247-55.
     PubMed     Related articles    Abstract available
     
     
     
176. RAFFOUL JJ , Banerjee S, Singh-Gupta V, Knoll ZE, et al
     Down-regulation of Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 Expression by Soy Isoflavones Enhances Prostate Cancer Radiotherapy In vitro and In vivo.
     Cancer Res. 2007;67:2141-9.
     PubMed     Related articles    Abstract available
     
     
     
177. RAJA GABAGLIA C , Diaz de Durana Y, Graham FL, Gauldie J, et al
     Attenuation of the glucocorticoid response during Ad5IL-12 adenovirus vector treatment enhances natural killer cell-mediated killing of MHC class I-negative LNCaP prostate tumors.
     Cancer Res. 2007;67:2290-7.
     PubMed     Related articles    Abstract available
     
     
     
178. POSPISIL P , Wang K, Al Aowad AF, Iyer LK, et al
     Computational modeling and experimental evaluation of a novel prodrug for targeting the extracellular space of prostate tumors.
     Cancer Res. 2007;67:2197-205.
     PubMed     Related articles    Abstract available
     
     
     
179. LI M , Zhang Z, Hill DL, Wang H, et al
     Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway.
     Cancer Res. 2007;67:1988-96.
     PubMed     Related articles    Abstract available
     
     
     February 2007
180. CHEN D , Cui QC, Yang H, Barrea RA, et al
     Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts.
     Cancer Res. 2007;67:1636-44.
     PubMed     Related articles    Abstract available
     
     
     
181. BIRLE DC , Hedley DW
     Suppression of the hypoxia-inducible factor-1 response in cervical carcinoma xenografts by proteasome inhibitors.
     Cancer Res. 2007;67:1735-43.
     PubMed     Related articles    Abstract available
     
     
     
182. DAS S , Hahn Y, Nagata S, Willingham MC, et al
     NGEP, a prostate-specific plasma membrane protein that promotes the association of LNCaP cells.
     Cancer Res. 2007;67:1594-601.
     PubMed     Related articles    Abstract available
     
     
     
183. JI Q , Chang L, Stanczyk FZ, Ookhtens M, et al
     Impaired Dihydrotestosterone Catabolism in Human Prostate Cancer: Critical Role of AKR1C2 as a Pre-Receptor Regulator of Androgen Receptor Signaling.
     Cancer Res. 2007;67:1361-9.
     PubMed     Related articles    Abstract available
     
     
     
184. GARCIA-HERNANDEZ MDE L , Gray A, Hubby B, Kast WM, et al
     In vivo Effects of Vaccination with Six-Transmembrane Epithelial Antigen of the Prostate: A Candidate Antigen for Treating Prostate Cancer.
     Cancer Res. 2007;67:1344-51.
     PubMed     Related articles    Abstract available
     
     
     
185. TURLEY RS , Finger EC, Hempel N, How T, et al
     The Type III Transforming Growth Factor-{beta} Receptor as a Novel Tumor Suppressor Gene in Prostate Cancer.
     Cancer Res. 2007;67:1090-8.
     PubMed     Related articles    Abstract available
     
     
     
186. VERRAS M , Lee J, Xue H, Li TH, et al
     The Androgen Receptor Negatively Regulates the Expression of c-Met: Implications for a Novel Mechanism of Prostate Cancer Progression.
     Cancer Res. 2007;67:967-75.
     PubMed     Related articles    Abstract available
     
     
     
187. PULUKURI SM , Estes N, Patel J, Rao JS, et al
     Demethylation-linked activation of urokinase plasminogen activator is involved in progression of prostate cancer.
     Cancer Res. 2007;67:930-9.
     PubMed     Related articles    Abstract available
     
     
     
188. LITTLE JL , Wheeler FB, Fels DR, Koumenis C, et al
     Inhibition of fatty acid synthase induces endoplasmic reticulum stress in tumor cells.
     Cancer Res. 2007;67:1262-9.
     PubMed     Related articles    Abstract available
     
     
     
189. NAKAI Y , Nelson WG, De Marzo AM
     The dietary charred meat carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine acts as both a tumor initiator and promoter in the rat ventral prostate.
     Cancer Res. 2007;67:1378-84.
     PubMed     Related articles    Abstract available
     
     
     January 2007
190. WANG H , McKnight NC, Zhang T, Lu ML, et al
     SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells.
     Cancer Res. 2007;67:528-36.
     PubMed     Related articles    Abstract available
     
     
     
191. CANO P , Godoy A, Escamilla R, Dhir R, et al
     Stromal-epithelial cell interactions and androgen receptor-coregulator recruitment is altered in the tissue microenvironment of prostate cancer.
     Cancer Res. 2007;67:511-9.
     PubMed     Related articles    Abstract available
     
     
     
192. DOLLOFF NG , Russell MR, Loizos N, Fatatis A, et al
     Human bone marrow activates the Akt pathway in metastatic prostate cells through transactivation of the alpha-platelet-derived growth factor receptor.
     Cancer Res. 2007;67:555-62.
     PubMed     Related articles    Abstract available
     
     
     
193. BOWEN C , Stuart A, Ju JH, Tuan J, et al
     NKX3.1 homeodomain protein binds to topoisomerase I and enhances its activity.
     Cancer Res. 2007;67:455-64.
     PubMed     Related articles    Abstract available
     
     
     
194. CANENE-ADAMS K , Lindshield BL, Wang S, Jeffery EH, et al
     Combinations of tomato and broccoli enhance antitumor activity in dunning r3327-h prostate adenocarcinomas.
     Cancer Res. 2007;67:836-43.
     PubMed     Related articles    Abstract available
     
     
     
195. GOLDSTEIN D , Gofrit O, Nyska A, Benita S, et al
     Anti-HER2 cationic immunoemulsion as a potential targeted drug delivery system for the treatment of prostate cancer.
     Cancer Res. 2007;67:269-75.
     PubMed     Related articles    Abstract available
     
     
     
196. WANG J , Wang J, Dai J, Jung Y, et al
     A glycolytic mechanism regulating an angiogenic switch in prostate cancer.
     Cancer Res. 2007;67:149-59.
     PubMed     Related articles    Abstract available
     
     
     
197. BUTCHER NJ , Tetlow NL, Cheung C, Broadhurst GM, et al
     Induction of human arylamine N-acetyltransferase type I by androgens in human prostate cancer cells.
     Cancer Res. 2007;67:85-92.
     PubMed     Related articles    Abstract available
     
     
     
198. HUFFMAN DM , Johnson MS, Watts A, Elgavish A, et al
     Cancer progression in the transgenic adenocarcinoma of mouse prostate mouse is related to energy balance, body mass, and body composition, but not food intake.
     Cancer Res. 2007;67:417-24.
     PubMed     Related articles    Abstract available
     
     
     December 2006
199. SRINIVASAN S , Ranga RS, Burikhanov R, Han SS, et al
     Par-4-Dependent Apoptosis by the Dietary Compound Withaferin A in Prostate Cancer Cells.
     Cancer Res. 2006;.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
200. HESS-WILSON JK , Daly HK, Zagorski WA, Montville CP, et al
     Mitogenic action of the androgen receptor sensitizes prostate cancer cells to taxane-based cytotoxic insult.
     Cancer Res. 2006;66:11998-2008.
     PubMed     Related articles    Abstract available
     
     
     
201. BANDYOPADHYAY S , Wang Y, Zhan R, Pai SK, et al
     The Tumor Metastasis Suppressor Gene Drg-1 Down-regulates the Expression of Activating Transcription Factor 3 in Prostate Cancer.
     Cancer Res. 2006;66:11983-90.
     PubMed     Related articles    Abstract available
     
     
     
202. DAVIS JN , Wojno KJ, Daignault S, Hofer MD, et al
     Elevated E2F1 Inhibits Transcription of the Androgen Receptor in Metastatic Hormone-Resistant Prostate Cancer.
     Cancer Res. 2006;66:11897-906.
     PubMed     Related articles    Abstract available
     
     
     
203. GAVRIELIDES MV , Gonzalez-Guerrico AM, Riobo NA, Kazanietz MG, et al
     Androgens Regulate Protein Kinase C{delta} Transcription and Modulate Its Apoptotic Function in Prostate Cancer Cells.
     Cancer Res. 2006;66:11792-801.
     PubMed     Related articles    Abstract available
     
     
     
204. PELLEY RP , Chinnakannu K, Murthy S, Strickland FM, et al
     Calmodulin-Androgen Receptor (AR) Interaction: Calcium-Dependent, Calpain-Mediated Breakdown of AR in LNCaP Prostate Cancer Cells.
     Cancer Res. 2006;66:11754-62.
     PubMed     Related articles    Abstract available
     
     
     
205. MOREY SR , Smiraglia DJ, James SR, Yu J, et al
     DNA methylation pathway alterations in an autochthonous murine model of prostate cancer.
     Cancer Res. 2006;66:11659-67.
     PubMed     Related articles    Abstract available
     
     
     
206. ZERBINI LF , Czibere A, Wang Y, Correa RG, et al
     A Novel Pathway Involving Melanoma Differentiation Associated Gene-7/Interleukin-24 Mediates Nonsteroidal Anti-inflammatory Drug-Induced Apoptosis and Growth Arrest of Cancer Cells.
     Cancer Res. 2006;66:11922-31.
     PubMed     Related articles    Abstract available
     
     
     
207. GHOSH JC , Dohi T, Raskett CM, Kowalik TF, et al
     Activated checkpoint kinase 2 provides a survival signal for tumor cells.
     Cancer Res. 2006;66:11576-9.
     PubMed     Related articles    Abstract available
     
     
     
208. GONZALEZ-GRONOW M , Cuchacovich M, Llanos C, Urzua C, et al
     Prostate Cancer Cell Proliferation In vitro Is Modulated by Antibodies against Glucose-Regulated Protein 78 Isolated from Patient Serum.
     Cancer Res. 2006;66:11424-31.
     PubMed     Related articles    Abstract available
     
     
     
209. KAHL P , Gullotti L, Heukamp LC, Wolf S, et al
     Androgen Receptor Coactivators Lysine-Specific Histone Demethylase 1 and Four and a Half LIM Domain Protein 2 Predict Risk of Prostate Cancer Recurrence.
     Cancer Res. 2006;66:11341-7.
     PubMed     Related articles    Abstract available
     
     
     November 2006
210. LINDSTROM S , Wiklund F, Adami HO, Balter KA, et al
     Germ-Line Genetic Variation in the Key Androgen-Regulating Genes An